Non-Small Cell Lung Cancer — A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer
Citation(s)
A Randomized Phase 3 Study of Two Doses of Alimta in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed a Prior Platinum-Containing Chemotherapy